| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |